The transcriptional coactivator Cbp regulates self-renewal and differentiation in adult hematopoietic stem cells. by Chan, WI et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The transcriptional coactivator Cbp regulates self-renewal and
differentiation in adult hematopoietic stem cells.
Citation for published version:
Chan, WI, Hannah, RL, Dawson, MA, Pridans, C, Foster, D, Joshi, A, Gottgens, B, Van Deursen, JM &
Huntly, BJP 2011, 'The transcriptional coactivator Cbp regulates self-renewal and differentiation in adult
hematopoietic stem cells.' Molecular and Cellular Biology, vol 31, no. 24, pp. 5046-5060. DOI:
10.1128/MCB.05830-11
Digital Object Identifier (DOI):
10.1128/MCB.05830-11
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Molecular and Cellular Biology
Publisher Rights Statement:
Copyright © 2011, American Society for Microbiology. All Rights Reserved.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 28. Apr. 2017
MOLECULAR AND CELLULAR BIOLOGY, Dec. 2011, p. 5046–5060 Vol. 31, No. 24
0270-7306/11/$12.00 doi:10.1128/MCB.05830-11
Copyright © 2011, American Society for Microbiology. All Rights Reserved.
The Transcriptional Coactivator Cbp Regulates Self-Renewal and
Differentiation in Adult Hematopoietic Stem Cells
Wai-In Chan,1 Rebecca L. Hannah,1 Mark A. Dawson,1 Clare Pridans,1† Donna Foster,1
Anagha Joshi,1 Berthold Go¨ttgens,1 Jan M. Van Deursen,2 and Brian J. P. Huntly1,3*
Department of Haematology, University of Cambridge, Cambridge Institute for Medical Research, Hills Road, Cambridge CB2 0XY,
United Kingdom1; Department of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota
559052; and Cambridge University Foundation Hospital Trust, Hills Road, Cambridge CB2 2QQ, United Kingdom3
Received 20 June 2011/Returned for modification 30 July 2011/Accepted 9 October 2011
The transcriptional coactivator Cbp plays an important role in a wide range of cellular processes, including
proliferation, differentiation, and apoptosis. Although studies have shown its requirement for hematopoietic
stem cell (HSC) development, its role in adult HSC maintenance, as well as the cellular and molecular
mechanisms underlying Cbp function, is not clear. Here, we demonstrate a gradual loss of phenotypic HSCs
and differentiation defects following conditional ablation of Cbp during adult homeostasis. In addition,
Cbp-deficient HSCs reconstituted hematopoiesis with lower efficiency than their wild-type counterparts, and
this response was readily exhausted under replicative stress. This phenotype relates to an alteration in cellular
fate decisions for HSCs, with Cbp loss leading to an increase in differentiation, quiescence, and apoptosis.
Genome-wide analyses of Cbp occupancy and differential gene expression upon Cbp deletion identified HSC-
specific genes regulated by Cbp, providing a molecular basis for the phenotype. Finally, Cbp binding signifi-
cantly overlapped at genes combinatorially bound by 7 major hematopoietic transcriptional regulators, linking
Cbp to a critical HSC transcriptional regulatory network. Our data demonstrate that Cbp plays a role in adult
HSC homeostasis by maintaining the balance between different HSC fate decisions, and our findings identify
a putative HSC-specific transcriptional network coordinated by Cbp.
The cyclic AMP response element binding protein (CREB)-
binding protein (CREBBP; here, CBP or Cbp) and its paral-
ogue, p300, are large multidomain proteins with transcrip-
tional coactivator properties that participate in numerous
cellular processes during development and homeostasis (10).
They modulate locus-specific transcription by a number of
separate mechanisms, including their direct catalytic activity,
which can acetylate both histone (2) and nonhistone (11) pro-
teins, as well as through multiple protein-protein interactions
with transcription factors, chromatin-remodeling complexes,
and the basal transcriptional machinery (3). Furthermore,
through interaction with multiple components within wider
transcriptional networks, Cbp/p300 may further integrate and
orchestrate whole transcriptional programs.
Precise temporal and spatial control of specific transcrip-
tional programs is required for the development, maintenance,
and differentiation of organ systems. Strong evidence has
linked Cbp function with both normal and malignant hemato-
poiesis. Cbp and p300 have been demonstrated to have tumor
suppressor roles in the development of hematological malig-
nancies in mice (18, 23). Germ line mutations of CBP occur in
the cancer predisposition syndrome Rubinstein-Taybi syn-
drome (35). CBP is also the direct target of chromosomal
translocations associated with acute myeloid leukemia (AML),
for which its C terminus is fused to the chromatin modifiers
MLL (MLL1) and MOZ (MYST3) (7, 39). Previous studies
have shown that Cbp and p300 functions are required for early
embryonic development as well as hematopoietic stem cell
(HSC) specification. Homozygous loss of either Cbp or p300
leads to embryonic lethality between embryonic day 9 (E9) and
E11.5 due to defects in neuralation and other proliferative
defects (23, 29, 30, 41, 47). Cbp/ embryos exhibit pallor and
demonstrate defects in primitive hematopoiesis (30). Further-
more, Cbp/ embryonic stem (ES) cells contributed signifi-
cantly to other tissues but failed to generate any hematopoietic
changes in chimeric animals (34). Studies of Cbp and p300
heterozygous mice, where one allele of Cbp is already lost in
developing HSCs and in other tissues, have suggested differ-
ential roles for the paralogues: for Cbp in HSC self-renewal
and for p300 in hematopoietic differentiation during early de-
velopment (34). Studies have shown that some transcription
factors, such as Runx1, that are critical during early-stage he-
matopoiesis become dispensable in adult HSC maintenance
(16). Although studies of adult mice have demonstrated the
importance of Cbp and p300 for B- and T-cell development
(19, 46), no studies have demonstrated the consequences of
Cbp deficiency in normal adult HSC maintenance and func-
tion. A recent study also suggested a potential role for Cbp in
the hematopoietic microenvironment (53). Despite all these
studies, the cellular mechanisms as well as the hematopoietic
transcriptional network by which Cbp regulates hematopoiesis
and adult HSC function have not been addressed. Here, using
functional studies of a Cbp conditional knockout mouse model
together with integrated genomic analyses, we demonstrate
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that Cbp regulates HSC quiescence, apoptosis, and differenti-
ation, and we identify putative hematopoietic transcriptional
networks coordinated by Cbp.
MATERIALS AND METHODS
Mice. Cbp conditional knockout mice (18) were bred with Mx-Cre transgenic
mice (22), both on the C57BL/6 background. To induce Cre-mediated recombi-
nation, 6- to 10-week-old mice were administered 5 doses of poly(I)  poly(C)
(300 g per dose; Sigma) by intraperitoneal injection every other day over 10
days. Deletion efficiency was determined by PCR of genomic DNA extracted
from various tissues. Peripheral blood (PB) samples were taken from the lateral
saphenous vein and collected in EDTA-treated tubes (Sarstedt, Germany). Au-
tomated total and differential blood cells were counted using a Vet abc auto-
mated counter (Scil Animal Care, Viernheim, Germany). All mice were housed
in a pathogen-free animal facility. Experiments were conducted under UK Home
Office regulations.
Flow cytometry analysis. Single-cell suspensions of bone marrow (BM) cells
were prepared by flushing both femurs and tibiae and by obtaining spleen cells,
with cell populations homogenized with Dulbecco’s phosphate-buffered saline
(DPBS; Invitrogen) supplemented with 2% fetal bovine serum (FBS; Sigma).
Cells were filtered through a 70-m nylon cell strainer (BD Biosciences). All
BM, spleen, and PB samples were treated with red blood cell lysis buffer (5
PRIME, Germany) prior to the subsequent experiments. Cell numbers were
determined using a CASY cell counter (Scha¨rfe System GmbH, Germany). All
staining was performed in DPBS with 0.1% bovine serum albumin and 1 mM
EDTA. Antibodies used were as follows: affinity-purified rat anti-mouse lineage
markers CD4, CD45R, LY-6C/G, TER119, CD19, and CD8a (all from Invitro-
gen) and CD3 (17A2; BD Biosciences). Other surface markers were as follows:
from BD Biosciences, c-Kit (2B8; phycoerythrin [PE] conjugated), CD45.1 (A20;
PE conjugated), CD45.2 (104; fluorescein isothiocyanate [FITC] conjugated),
and CD4 (RM4-5; PE-Cy7 conjugated); from eBioscience, CD127 (interleukin-7
receptor  [IL-7R]; A7R34; biotin conjugated), CD135 (Flk-2/flt-3; A2F10;
biotin conjugated), CD16/32 (93; biotin conjugated), CD34 (RAM34; FITC
conjugated), Ly-6G (Gr1; PE-Cy7 conjugated), CD3 (PE-Cy7 conjugated),
CD11b (M1/70; allophycocyanin [APC] conjugated), and streptavidin–PE-Cy7
conjugated secondary antibody; from Invitrogen, Ly-6A/E (Sca-1, D7; Alexa
Fluor 647 conjugated), CD45R (APC conjugated), and Pacific blue anti-mouse
IgG F(AB)2 fragments. Flow cytometry analysis was performed on a CyAn ADP
flow cytometer (Dako). All data were analyzed with FlowJo software (Tree Star,
Inc.).
Isolation of the LSK population by flow sorting. BM cells were harvested from
femurs and tibiae from mice with the same genotype at 4 weeks after
poly(I)  poly(C) treatment. BM cells were first stained with affinity-purified rat
anti-mouse lineage markers (CD4, CD3, CD45R, LY-6C/G, TER119, CD19, and
CD8a [listed above]). Lineage-positive cells were depleted using Dynabeads
(sheep anti-rat IgG; Invitrogen) according to the manufacturer’s instructions.
Lineage-depleted BM cells were labeled with c-Kit PE-conjugated (BD Biosci-
ences) and Sca-1 Alexa Fluor 647-conjugated (Invitrogen) antibodies. 7-Amino-
actinomycin D (7-AAD) was added to exclude dead cells. The LSK population
(Lin c-Kithi Sca1hi) was sorted using a MoFlo cell sorter (Beckman Coulter).
Cell cycle and apoptosis analyses. Mice were injected intraperitoneally with 1
mg of bromodeoxyuridine (BrdU; BD Biosciences). BM cells were collected 24 h
later and stained with surface markers as stated above prior to BrdU detection,
following the manufacturer’s instructions (BrdU flow kit; BD Biosciences). For
5-fluorouracil (5-FU) treatment, 1 dose of 5-FU was injected intraperitoneally at
a dose of 150 mg/kg of body weight. BM cells were collected 10 days later for
fluorescence-activated cell sorting (FACS) analysis. The Ki-67 staining proce-
dure was similar to that for BrdU detection, except a Ki-67–FITC antibody (BD
Biosciences) was used without DNase treatment. Annexin V-FITC staining
(Miltenyi Biotec) was performed according to the manufacturer’s instructions.
DNA content was labeled with 7-AAD (BD Biosciences).
Bone marrow transplantation assays. Unfractionated BM cells from 6- to
10-week-old Cbp Mx or Cbp wild-type (wt) littermates (CD45.2) were collected
as donor cells 4 weeks after poly(I)  poly(C) treatment. For competitive trans-
plantations, these cells were mixed with competitor BM cells (CD45.1) at dif-
ferent ratios (1:1 and 3:1). A total of 1  106 cells were injected intravenously
into lethally irradiated (550 rads; 2 doses) C57BL/6 recipients (CD45.1/45.2). For
the serial transplantation experiment, 1 106 donor cells (CD45.2) were injected
intravenously into lethally irradiated (550 rads; 2 doses) C57BL/6 recipients
(CD45.1). At 16 weeks after the primary transplantation, 1  106 unfractionated
BM cells from the primary recipients were pooled and injected into the second-
ary recipients. The whole procedure was repeated for the tertiary transplanta-
tion. PB chimerism was monitored by flow cytometry analysis monthly. Recon-
stitution of BM cells in the primary, secondary, and tertiary recipients was
assessed at 16 weeks posttransplantation.
Homing assay. Whole BM cells were collected from Cbp wt or Cbp Mx mice
4 weeks after poly(I)  poly(C) treatment. Single cells were labeled using a
Vybrant carboxyfluorescein diacetate succinimidyl ester (CFDA SE [CFSE]) cell
tracer kit (Invitrogen) for 15 min at 37°C. BM cells were washed in DPBS
(Invitrogen) to remove excess dye. A total of 5 million labeled BM cells were
transplanted into lethally irradiated recipients (CD45.1). BM cells from recipi-
ents were collected 24 h after transplantation. CFSE-positive stem and progen-
itor populations were assessed by flow cytometry.
Microarray analysis. Total RNA was extracted from pooled sorted LSK cells
by using TRIzol reagent (Invitrogen) and a standard protocol. Five nanograms of
RNA was amplified using the Ovation RNA amplification system V2 (NuGEN)
and labeled with biotin. The biotin-labeled cDNA samples were then hybridized
onto the Illumina mouse WG-6 v2 bead chip array, following the manufacturer’s
instructions. Probe selection was performed using the R package Lumi (9).
Probes that were successfully detected over background (P values of 0.01 in
Lumi) in at least one sample were selected for subsequent analyses. Data were
transformed using variance stabilization followed by normalization using quan-
tile normalization (25). The comparisons in expression levels between samples
were performed using the R package Limma. Probes differentially expressed (P
values of 0.05) were selected for subsequent analyses.
GSEA. Gene set enrichment analysis (GSEA) software and all curated gene
sets (c2.All.v3.0.symbols.gmt) were obtained from the GSEA website (http:
//www.broadinstitute.org/gsea/index.jsp) (37). Gene enrichment analyses were
performed using the default settings.
Chromatin immunoprecipitation and sequencing assay (ChIP-seq) and data
analysis. HPC-BM cells (33) were maintained in Iscove’s modified Dulbecco’s
medium (IMDM) supplemented with 10% FBS, monothiolglycerol (MTG;
Sigma), 100 ng/ml of stem cell factor, and 10 ng/ml of human IL-6. Cells were
cross-linked with 1% formaldehyde. Immunoprecipitation was performed using
rabbit polyclonal Cbp antibody (ab2832; Abcam) and rabbit IgG antibody (Ab-
cam) as a negative control as described previously (8). Each sample was ampli-
fied and sequenced using an Illumina Genome Analyzer IIx. All sequencing
reads for each sample were converted into density maps (.wig files). Peak calling
was performed using the peak-finding program MACS (model-based analysis of
ChIP-Seq) (52) as described in reference 45 with the following modified com-
mand line parameters for MACS: mfold, 16; t size, 35; bw, 100; P  1e5; gsize,
1,870,000,000; no lambda. All peaks were standardized to be 400 bp wide. Data
were mapped to mouse reference genome (mm9) and displayed as UCSC ge-
nome browser custom tracks. For gene mapping and peak distribution analysis,
genes were mapped to peaks by examining a 100-kb region around each peak and
linking the nearest 3 and 5 genes to that peak. If a gene had a transcription start
site within 1,000 bp from the peak, then only that gene was considered. Peak
coordinates were checked for overlap with genes. If a peak overlapped 1,000 bp
upstream of a gene, it was assigned as a promoter peak. The remaining peaks
were either assigned as intragenic, if overlapping a gene by at least 1 bp, or
intergenic, if not overlapping a gene or promoter region. The motif-finding
program MEME (1) was used to find overrepresented motifs in three groups of
peaks with the following parameters: -dna -nmotifs, 20; -evt, 0.01; -maxsize,
1,000,000. The middle 100 bp was taken for all peak regions, and peaks were
excluded from analysis if they had more than 40% of repetitive sequence. The
motif comparison tool TOMTOM (12) was then used to identify the motifs found
by MEME.
Quantitative real-time PCR. For gene expression analysis, RNA from flow-
sorted LSK cells was extracted using TRIzol reagent (Invitrogen) following the
standard protocol. cDNA was synthesized using a SuperScript VILO cDNA
synthesis kit (Invitrogen) following the manufacturer’s instructions. Quantitative
reverse transcription-PCR (qRT-PCR) was carried out with SYBR green PCR
master mix in the ABI Prism 7000 system (Applied Biosystems). The expression
level of RNA was calculated using the standard curve method, normalized to the
expression of -actin. Results were from 2 individual PCRs from 3 individual
samples. For ChIP-PCR, genomic DNA immunoprecipitated with the Cbp or
rabbit IgG antibody was subjected to real-time PCR as described above. Input
DNA was used to generate a standard curve. Enrichment of binding at particular
genomic loci is presented as the percentage of the input DNA. All PCR results
were from two individual experiments. Primer sequences are available upon
request.
Statistical analysis. An unpaired Student’s t test was used for all analyses,
within the GraphPad Prism4 software (GraphPad Software, Inc.).
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FIG. 1. Deletion of Cbp in adult bone marrow affects lineage differentiation. (A) Genotyping of genomic DNA extracted from different tissues
collected from Cbp wt or Cbp Mx animals 4 and 28 weeks after poly(I)  poly(C) (pIpC) treatment demonstrated stable and nearly complete
excision of Cbp in BM and PB. fl/fl and 	/	 represent Cbp floxed and null alleles, respectively. (B) Comparisons of BM cellularity (2 tibiae and
2 femurs) and spleen and liver weights between Cbp wt and Cbp Mx mice at 4 weeks and 28 weeks after poly(I)  poly(C) treatment. No differences
were noted at either time point (n 
 6 for each genotype). (C) PB counts of Cbp wt and Cbp Mx over 28 weeks after poly(I)  poly(C) treatment.
Deletion of Cbp led to a significant decrease in platelet numbers, while white blood cell (WBC) and hemoglobin (HGB) counts were not affected.
(D) FACS analyses of PB, BM, and thymus cells from both genotypes at 4 and 28 weeks after poly(I)  poly(C) treatment. The bias toward myeloid
lineages at the expense of lymphoid lineages became more pronounced at the 28-week time point. Results are shown as means  standard errors
of the means (n 
 15 for each genotype at 4 weeks; n  8 for each genotype at 28 weeks). *, P  0.05; **, P  0.01; ***, P  0.001. DN, CD4
and CD8 double-negative cells.
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FIG. 2. Modest alterations in the BM stem and progenitor compartments occur following Cbp deletion. (A) Representative FACS plots of BM
compartments of Cbp wt and Cbp Mx mice 4 weeks after poly(I)  poly(C) treatment. (B) Graphs showing frequencies of LSK and progenitors and
their subpopulations 4 weeks after poly(I)  poly(C)-induced Cbp excision. The ratio of myeloid progenitor frequency to LSK frequency is shown
(with the ratio for Cbp wt mice normalized to 1). Results shown are means  standard errors of the means (SEM; n  6). (C) Cbp-deficient LSK
cells do not mobilize to the spleen. Representative FACS plots show the LSK and progenitor compartments (gates on Lin) in spleens from Cbp
wt and Cbp Mx mice 4 weeks after poly(I)  poly(C) treatment. Data are shown as means  SEM (n  4). (D) Frequencies of BM subpopulations
analyzed at 28 weeks post-poly(I)  poly(C) treatment. Results are means  SEM (n  5). *, P  0.05.
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FIG. 3. Cbp-deficient BM cells are capable of BM reconstitution with reduced efficiency. (A) Noncompetitive transplantation. Representative
FACS plots of PB cells from recipients transplanted with either Cbp wt or Cbp Mx cells (left panel). The right panel shows the contributions of
Cbp wt and Mx cells to the recipient PB cells over 16 weeks following transplantation. Results are means  standard errors of the means (SEM;
n  10 for each genotype). (B) Graph demonstrating the percentages of donor-derived B-cell (B220), T-cell (CD3), and granulocytic (Mac-1
Gr-1) lineages in the PB of recipients at 16 weeks after the noncompetitive transplantation shown in panel A. (C) Cbp-deficient BM cells show
no obvious defect in homing. Representative FACS plots are shown for BM cells from recipients transplanted with either Cbp wt or Cbp Mx BM
cells that were labeled with CFSE prior to transplantation. The graphs on the right show percentages of total CFSE, CFSE progenitor, and
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Microarray data accession number. Microarray and ChIP-seq data have been
deposited into the NCBI Gene Expression Omnibus portal under the accession
number GSE25274.
RESULTS
Deletion of Cbp alters hematopoietic lineage differentiation.
To study the role of Cbp in the adult hematopoietic system, we
crossed Cbp conditional knockout mice (Cbp fl/fl) (18) with
Mx-Cre transgenic mice (22), allowing Cre-mediated deletion
of Cbp in the hematopoietic system upon injection of
poly(I)  poly(C). Cre-mediated recombination at this genomic
locus has been previously demonstrated to ablate Cbp, with no
detectable Cbp protein expression (18, 19, 46). Efficient re-
combination was confirmed by PCR of genomic DNA at both
4 and 28 weeks post-poly(I)  poly(C) treatment (Fig. 1A). At
both time points, no gross phenotypic abnormalities were ob-
served in Cbp fl/fl; Mx-Cre mice (referred to here as Cbp Mx)
and Cbp fl/fl; Mx-Cre littermate control mice (referred to
here as Cbp wt). BM cellularity and spleen and liver weights
were similar between the two genotypes (Fig. 1B). In serial
measures of PB, no differences were observed in total white
blood cell counts or hemoglobin levels between genotypes.
However, we observed a significant decrease in platelet num-
bers in Cbp Mx mice, which was evident from as early as 4
weeks post-poly(I)  poly(C) treatment (Fig. 1C). Further-
more, at 4 weeks after Cbp deletion, flow cytometry analysis of
PB showed a decline in the frequencies of B-cell (B220) and
T-cell (CD4) lineages in Cbp Mx mice, as has been previously
reported with excision of Cbp in later lymphoid compartments
(19, 46). This decrease was accompanied by a concomitant
increase in the percentage of myeloid cells (Mac-1 Gr-1)
(Fig. 1D). This differentiation bias toward the myeloid lineage
became more marked over time, and by 28 weeks after
poly(I)  poly(C) treatment the myeloid lineage was increased
by around 3-fold in Cbp Mx mice, while both B- and T-cell
lineages were decreased by 2.5-fold in comparison to Cbp wt
mice (Fig. 1D). This pattern was recapitulated in BM cells at
both time points, although it was less evident (Fig. 1D). It has
previously been shown that deleting Cbp in thymocytes results
in increased numbers of CD8 single-positive (SP) cells and
decreased numbers of double-positive (DP) cells (18, 19). We
observed a similar progressive phenotype at both time points.
We and others have shown that poly(I)  poly(C)-induced Cre-
mediated excision under the control of the Mx1 promoter is
less efficient in thymocytes and spleen cells (Fig. 1A). There-
fore, the initial phenotype we observed may have been diluted
by the remaining Cbp fl/fl unexcised populations. Taken to-
gether, the above data suggest that deletion of Cbp in HSCs
biases toward myeloid differentiation, resulting in thrombocy-
topenia, lymphopenia, and myeloid cell expansion over time.
Loss of Cbp alters the composition of the hematopoietic
stem and progenitor compartment. The differentiation defects
observed in Cbp Mx mice may reflect possible alterations in the
hematopoietic stem and progenitor cell (HSPC) compartment.
We therefore examined the effect of Cbp deletion on the com-
position of HSPCs. At 4 weeks post-poly(I)  poly(C) treat-
ment, we observed a mild decrease in the frequency of the
HSC-enriched LSK population (Lin c-Kithi Sca1) and a
corresponding increased frequency of the myeloid progenitor
compartment (Lin IL-7R c-Kithi Sca1) (Fig. 2A and B).
When the ratio of progenitors to LSK cells was compared (Fig.
2B), there was over a 2-fold relative increase in the production
of progenitors in Cbp Mx compared to wt mice. However,
there was no significant difference in composition within the
heterogeneous LSK compartment, as determined by the fre-
quencies of the long-term HSC (LT-HSC; L K S CD34
Flt3), short-term HSC (ST-HSC; L K S CD34 Flt),
and lymphoid-primed multipotent progenitor compartments
(LMPP; L K S CD34 Flt3) between Cbp Mx and wt
mice (Fig. 2B). Within the myeloid progenitor compartment,
no differences were noted in the frequency of the common
myeloid progenitor (CMP) population (L K S CD34
CD16/32int) between the two genotypes. However, a small in-
crease in the granulocyte-monocyte progenitor (GMP; L K
S CD34 CD16/32hi) frequency, with a corresponding de-
crease in the megakaryocyte-erythroid progenitor cell (MEP;
L K S CD34 CD16/32lo) frequency was noted in Cbp Mx
mice. Although nonsignificant, this difference may have con-
tributed to the thrombocytopenia and myeloid lineage expan-
sion observed in the PB over time. The common lymphoid
progenitor (CLP; Lin IL-7R c-Kitint Sca1int) frequencies
between the two genotypes were also similar.
The changes in the HSPC compartment in Cbp Mx mice
were progressive, and at 28 weeks post-poly(I)  poly(C) treat-
ment, the frequency of LSK in Cbp Mx mice was significantly
reduced in comparison to Cbp wt mice (Fig. 2D). This reduc-
tion in LSK compartment size was not due to increased mo-
bilization or redistribution of stem and progenitor cells to the
spleen or PB (Fig. 2C and data not shown). Although the size
of the Cbp Mx LSK population was reduced, the ratio of
progenitor to LSK in Cbp Mx mice remained stable and was
still greater than twice that of Cbp wt mice (Fig. 2D). This
suggests that a bias directing HSC differentiation over self-
renewal is maintained over time following Cbp deletion, which
may, in turn, contribute to the gradual reduction of phenotypic
HSCs.
CFSE LSK cells of two genotypes detected in the recipient BM cells 24 h after transplantation. Data are means  SEM (n  6 for Cbp wt; n 
8 for Cbp Mx). (D) Competitive transplantation. Representative FACS analysis of PB cells from recipients transplanted with Cbp wt and Mx (test)
and competitor cells at a 3:1 ratio (left panel). Graphs show the contributions of Cbp wt and Mx cells to the recipient PB reconstitution over a
22-week period following transplantation at a 1:1 ratio (middle panel) and 3:1 ratio (right panel). Results are means  SEM (n  5 for each
genotype). *, P  0.05; **, P  0.01. (E) Deletion of Cbp in the BM niche does not significantly affect the reconstitution ability of wt donor BM
cells. The graph shows the contributions of wt donor cells (45.1) to the PB cells of Cbp wt or Cbp Mx recipients over 20 weeks after transplantation
(left panel). The right panel shows the percentages of different lineages derived from donor cells in the PB of these recipients at 20 weeks
posttransplantation. Results are means  SEM (n  5 for each genotype).
VOL. 31, 2011 Cbp DEFICIENCY ALTERS CELL FATE DECISIONS FOR HSCs 5051
5052
Cbp-deficient HSCs are capable of multilineage bone mar-
row reconstitution but engraft with decreased efficiency. We
next investigated if loss of Cbp also affected normal HSC
function. We first assessed the long-term multilineage bone
marrow reconstitution ability of Cbp-deficient BM cells in a
noncompetitive transplantation experiment. One million un-
fractionated BM cells from either Cbp Mx or Cbp wt mice
(CD45.2) were transplanted into lethally irradiated wild-type
recipients (congenic CD45.1). Donor contribution to recipient
PB reconstitution was monitored by flow cytometry at four
weekly intervals for 16 weeks after transplantation. As shown
in Fig. 3A, the degree of PB chimerism was similar between
mice transplanted with Cbp Mx and Cbp wt BM cells. In ad-
dition, the frequencies of donor-derived B- and T-cell lineages
in the PB of recipients transplanted with Cbp Mx cells were
reduced. This reduction in the lymphoid lineage resembled the
phenotype observed after deleting Cbp during homeostasis,
suggesting that the differentiation defects caused by Cbp defi-
ciency are predominantly cell autonomous (Fig. 3B). In keep-
ing with the normal reconstitution ability of Cbp Mx cells in
primary transplantation, no significant differences were ob-
served in the homing abilities of progenitor or LSK cells be-
tween Cbp wt and Cbp Mx cells (Fig. 3C).
We next examined the relative BM reconstitution efficiency
of Cbp-deficient BM cells in a competitive setting. Cbp Mx or
wt whole BM cells (test; CD45.2) were mixed with normal wt
competitor BM cells (competitor; CD45.1) at a ratio of 1:1 or
3:1 (test:competitor ratio) and subsequently transplanted into
recipient mice (CD45.1/45.2). Analyses of PB chimerism in
recipients showed a reduced contribution from Cbp Mx cells, in
comparison with Cbp wt cells, at both ratios (Fig. 3D). Taken
together, these data demonstrate that Cbp-deficient BM cells
are able to engraft and reconstitute lethally irradiated recipient
mice; however, they do so with a reduced efficiency.
It has been reported that Cre expression under the Mx1
promoter is also induced in the HSC microenvironment (51).
Moreover, it was shown recently that the Cbp/ microenvi-
ronment fails to maintain normal HSC function (53). To ex-
amine if deletion of Cbp in the HSC microenvironment during
homeostasis affects the reconstitution abilities of wt HSCs, we
transplanted wt whole BM cells (CD45.1) into lethally irradi-
ated Cbp wt or Cbp Mx recipients (CD45.2) 4 weeks after
poly(I)  poly(C) treatment. No difference in the levels of PB
chimerism or multilineage reconstitution could be detected
over 20 weeks posttransplantation between recipients of the
two genotypes (Fig. 3E). Although it is possible that excision
under the control of the Mx1 promoter may not totally delete
Cbp in all critical niche compartments, these data suggest that
deletion of Cbp in the HSC niche during homeostasis has little
effect on the engraftment and long-term multilineage recon-
stitution of donor cells.
Loss of Cbp leads to exhaustion of HSCs upon serial trans-
plantation. We further examined the effect of Cbp deficiency
on long-term HSC self-renewal under the replicative stress of
serial transplantation. Secondary transplantation was per-
formed 16 weeks after the initial transplantation, whereby 106
total BM mononuclear cells were harvested from the primary
recipients and transplanted into lethally irradiated secondary
recipients. This process was iteratively repeated into tertiary
recipients after another 16 weeks. As previously mentioned,
Cbp Mx BM cells were able to engraft primary recipients to a
similar level as Cbp wt cells (Fig. 3A). However, in the sec-
ondary recipients the contribution of Cbp Mx donor cells to
total PB, as well as to individual lineages, was dramatically
decreased compared to Cbp wt cells (Fig. 4A). In the tertiary
transplant recipients, Cbp Mx cells were virtually undetectable,
while Cbp wt cells still demonstrated a high level of engraft-
ment.
Consistent with the results for PB, Cbp Mx cells were able to
reconstitute total BM cells as well as the HSPCs in the primary
recipients. In the secondary recipients, Cbp Mx donor cells
showed decreased contributions to total BM cells and HSPCs
(Fig. 4B, top and middle panels). Notably, we observed a
significant reduction in the percentages of donor-derived LSK
in both primary and secondary recipients of Cbp Mx compared
to Cbp wt cells (Fig. 4B, lower panel). This recapitulates the
reduced LSK frequency observed in Cbp Mx mice after
poly(I)  poly(C) treatment (Fig. 2B and D), further indicating
a cell-autonomous defect in stem cell self-renewal. In the ter-
tiary recipients, virtually no evidence of Cbp Mx contribution
to hematopoiesis was seen, while Cbp wt cells still significantly
contributed to the total BM, LSK, and progenitor compart-
ments (Fig. 4B). These data demonstrate that, under replica-
tive stress, Cbp-deficient HSCs are exhausted, suggesting an
inability to sufficiently maintain the HSC pool through im-
paired self-renewal.
Aberrant regulation of the cell cycle and increased apoptosis
contribute to HSC exhaustion in Cbp-deficient mice. To fur-
ther investigate the cellular nature of our HSC exhaustion
phenotype, we next assessed the cell cycle and apoptotic char-
acteristics of Cbp-deficient HSPCs 4 weeks after
poly(I)  poly(C) treatment. At 4 weeks after poly(I)  poly(C)
administration, we detected a mild but statistically significant
increase in apoptosis in Cbp Mx LSK cells, but not in the
FIG. 4. Progressive exhaustion of Cbp-deficient HSCs under replicative stress. (A) The upper graphs show the contributions of Cbp wt and Mx
cells to reconstitution of the recipient PB cells over 16 weeks following the secondary (2nd) and tertiary (3rd) transplantations. The Cbp Mx
contribution was dramatically decreased in the secondary transplantation and extinguished in the tertiary. Contributions to different lineages of
PB cells are also shown (lower panels). Results are means  standard errors of the means (SEM; secondary transplantation, n  10 for each
genotype; tertiary transplantation, n  6 for each genotype). **, P  0.01; ***, P  0.001. (B) FACS analyses of BM chimerism in the primary,
secondary, and tertiary recipients. The upper panels show the contribution of donor-derived cells (CD45.2) to total BM cellularity. The middle
panels show the contribution of CD45.2 cells to the LSK and progenitor compartments (HSPCs). The lower panel shows the frequencies of
donor-derived LSK populations in the primary and secondary recipients of Cbp wt or Cbp Mx cells. Similar to the result for PB cells, the
contribution of the CD45.2 Cbp Mx cells to BM cellularity and HSPC dramatically decreased with successive transplantations, indicating a severe
defect in HSC self-renewal under replicative stress. All results are shown as means  SEM (n  5 for each genotype). *, P  0.05; **, P  0.01;
***, P  0.001.
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progenitor compartment, as assessed by staining with annex-
inV/7-AAD (Fig. 5A). In vivo BrdU incorporation showed no
obvious differences in the proportions of either LSK or pro-
genitors in S or G2/M phases in the absence of Cbp (Fig. 5B),
suggesting that loss of Cbp has no effect on cycling of stem and
progenitor cells. However, a noticeable increase in cells in
G0/G1 in both LSK and progenitor compartments prompted us
to further assess quiescent and cycling states, based on the
intracellular expression of ki-67 and 7-AAD staining (Fig. 5C).
Surprisingly, the LSK population from Cbp Mx mice demon-
strated an increase in quiescent (G0) cells and a concomitant
decrease in the G1 fraction. An increased proportion of qui-
escent cells was also demonstrated in the progenitor compart-
ment of Cbp Mx mice. In consonance with the BrdU analysis,
no change in the proportion of HSPCs in S/G2/M was observed
between Cbp Mx and Cbp wt animals (Fig. 5C), confirming that
deletion of Cbp had no obvious effect on stem and progenitor
cells that were able to enter the cell cycle. Taken together, the
above data demonstrated that deletion of Cbp leads to an
accumulation of stem and progenitor cells in the quiescent
state and an increase in apoptosis within the LSK compart-
ment during adult homeostasis. These cellular characteristics
further contribute to the HSC exhaustion phenotype we de-
scribe.
The Cbp-deficient HSC phenotype is exacerbated by in vivo
5-FU treatment. To gain further insights into the impaired
self-renewal of Cbp-deficient HSCs under replicative stress, we
challenged Cbp wt and Cbp Mx mice with one dose of 5-FU, 4
weeks after Cbp deletion, and monitored the recovery of the
HSPC compartments as well as the cell cycle characteristics of
these compartments. 5-FU treatment eliminated any cycling
hematopoietic cells and therefore induced HSCs into the cell
cycle to replenish the hematopoietic system. Ten days after
5-FU treatment, the LSK frequency in Cbp Mx mice was sig-
nificantly lower than in Cbp wt mice (Fig. 5D). We also ob-
served a marked reduction in the frequency of LT-HSCs and
ST-HSCs, with a concomitant increase in MPP frequency in
Cbp Mx mice, changes not apparent during homeostasis (Fig.
2B). Although total progenitor frequency was not altered,
there was a significant increase in the proportion of GMP and
a concomitant significant decrease in the proportion of MEP
when Cbp Mx mice were compared to Cbp wt mice (see Fig. S1
in our supplemental material posted at http://hscl.cimr.cam.ac
.uk/genomic_supplementary.html). These data show an accen-
tuation of the homeostatic phenotype and further demonstrate
preferential differentiation and granulocyte/monocyte produc-
tion (Fig. 5D). In addition, when we examined the cell cycle
status of LSK cells after 5-FU treatment, there was a signifi-
cant decrease in S/G2/M cycling LSK cells. These data together
further suggest that under replicative stress, Cbp-excised LSK
cells undergo increased differentiation and reduced cell cycle
progression, which together lead to exhaustion of HSCs.
Gene expression analysis identified candidate HSC path-
ways regulated by Cbp. Cbp is a global transcriptional coacti-
vator, interacting with numerous transcription factors, includ-
ing important hematopoietic regulators like Gata-1, Gata-2,
Runx2, and Rb1 (3). We therefore predicted that its loss would
result in an alteration of multiple, rather than single, transcrip-
tional programs. To identify alterations in global gene expres-
sion and the molecular mechanisms underlying the stem cell
and cell cycle defects, we performed microarray analysis in the
LSK populations of Cbp wt and Cbp Mx mice, a population
enriched for hematopoietic stem cells. The analysis was per-
formed at 4 weeks after Cbp deletion, the time point at which
we had already documented changes in differentiation, apop-
tosis, and the cell cycle. Microarray analysis identified 341
unique transcripts (187 upregulated and 154 downregulated)
differentially expressed (P  0.05) between Cbp Mx and wt
LSK for which the expression level varied by 1.4-fold
(log2, 
0.5) (Fig. 6A; see also our supplemental Table S1 at
http://hscl.cimr.cam.ac.uk/genomic_supplementary.html). The
overall change in gene expression level was modest, with only
around 30 genes showing greater-than-2-fold differences in
expression level. However, consistent with our data, others
have reported similar modest alterations in gene expression
after deleting Cbp in mature T and B cells, suggesting a more
subtle modulation of transcript levels upon Cbp loss (18, 46).
Genes differentially expressed in LSK included genes impli-
cated in the phenotypic abnormalities demonstrated in our
Cbp Mx mice: abnormal cell cycle control [upregulation of
Gfi1b and Cxcl12; downregulation of Ccnd1, Ccnd2,
Cdkn1a(p21), Rb1, and Mcm7], and altered differentiation (up-
regulation of myeloid differentiation genes, including Mpo,
Ela2, Cd16, and Ctsg; downregulation of lymphoid genes, in-
cluding Rag1) (Fig. 6A). The differential expression of a subset
of these genes was confirmed by qRT-PCR (Fig. 6B).
In order to gain further insights into pathways and cellular
processes altered by loss of Cbp, we next performed GSEA
FIG. 5. Cbp-deficient LSK and progenitor cells demonstrated alterations of quiescence and apoptosis. (A) Representative FACS plots of
annexin V/7-AAD staining on LSK and progenitor cells from Cbp wt and Cbp Mx mice. Percentages of apoptotic LSK and progenitor cells (annexin
V 7-AAD) from Cbp wt and Cbp Mx animals show increased apoptosis in LSK but not progenitors from Cbp Mx mice. Results shown are
means  standard errors of the means (SEM; n  8 for Cbp wt; n  9 for Cbp Mx). *, P  0.05. (B) Both Cbp wt and Mx mice were injected
with 1 mg of BrdU 24 h before analysis. Representative FACS plots show cell cycle distributions of LSK and progenitors in Cbp wt and Mx mice.
DNA content was stained with 7-AAD. Graphs show the percentages of cells in the different cell cycle phases. The proportions of LSK and
progenitor cells in S or G2/M were similar between Cbp wt and Mx mice, suggesting that deletion of Cbp does not affect the cycling stem and
progenitor cells. Data are mean SEM (n 4 for Cbp wt; n 5 for Cbp Mx). (C) The cell cycle status of LSK and progenitor cells was determined
by the combined expression of the proliferation marker ki67 and the DNA-staining dye 7-AAD. Representative FACS plots from both Cbp wt
and Cbp Mx mice are shown. Graphs show the proportions of LSK and progenitor cells at different stages of the cell cycle. Both Cbp Mx LSK and
progenitors demonstrated an increase in quiescent (G0) fractions. Results are shown as means  SEM (n  11 for Cbp wt; n  14 for Cbp Mx).
*, P  0.05; **, P  0.01. (D) Analysis of the LSK compartment under stress conditions. Cbp wt or Mx mice were treated with one dose of 5-FU,
4 weeks after poly(I)  poly(C) treatment. Graphs show the frequencies of LSK and its subpopulations 10 days after 5-FU treatment (left and
middle panels). The cell cycle status of the LSK compartment was determined based on the expression of Ki-67 and staining with the DNA dye
7-AAD (right panel). Results are means  SEM (N 
 6). *, P  0.05; ***, P  0.001.
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(http://www.broadinstitute.org/gsea) to compare our gene ex-
pression profile with all published curated gene sets (c2, ver-
sion 3). Among 1,978 unselected gene sets analyzed, 22 gene
sets were enriched in genes upregulated in Cbp/ LSK cells,
while 79 showed significant enrichment in genes downregu-
lated in Cbp/ LSK cells (nominal P value, 0.001). Inter-
estingly, the latter group included gene sets with genes down-
regulated in quiescent versus dividing human CD34
hematopoietic cells as well as genes related to the G1 cell cycle
checkpoint (Fig. 6C; see also Table S2 at http://hscl.cimr.cam
.ac.uk/genomic_supplementary.html), in agreement with the
cell cycle defect observed upon Cbp deletion. In addition, we
recently identified 927 target genes bound by 7 major hema-
topoietic transcriptional regulators (Scl/Lyl1/Gata2/Runx1/
Lmo2/Fli-1/Erg) in a hematopoietic stem and progenitor sys-
tem (45). This Heptad target gene set is highly enriched for
genes specifically expressed in HSCs. By GSEA, the Heptad
gene set showed a strong correlation with genes downregulated
in Cbp-deficient LSK cells (Fig. 6C; see also supplemental
Table S3 at http://hscl.cimr.cam.ac.uk/genomic_supplementary
.html). These data suggest that loss of Cbp may alter HSC
function through decreased expression of critical HSC-specific
genes regulated by these core hematopoietic transcription fac-
tors.
Genome-wide analysis of Cbp occupancy identifies the HSC-
specific transcriptional network coordinated by Cbp. Cbp ex-
ecutes its function by interacting with a number of transcrip-
tional regulators. The significant enrichment of Heptad target
genes in genes downregulated after loss of Cbp suggests that
Cbp may contribute to the regulatory network controlling nor-
mal hematopoiesis. We therefore performed ChIP-seq analysis
in HPC-BM cells to identify the putative HSC transcriptional
FIG. 6. Microarray analysis identified candidate genes regulated by Cbp. (A) Heat map showing probes differentially expressed more than
1.4-fold (up- or downregulated) between Cbp wt and Cbp Mx LSK cells (P  0.05). Selected genes, either up- or downregulated and proposed to
contribute to our cellular phenotypes, are listed to the right of the heat map. (B) qRT-PCR analysis for selected genes confirmed differential
expression levels for the majority of genes between Cbp wt and Mx LSK cells. Results are from 3 individual samples from each genotype and are
shown as means  standard errors of the means. Cbp wt samples were averaged and normalized to 1. (C) Representative GSEA, demonstrating
that both Heptad-bound genes (right panel) and genes downregulated in quiescent versus dividing HSCs (left panel) are strongly enriched within
genes downregulated in Cbp/ LSK (nominal P value, 0.001).
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network coordinated by Cbp. The small available number of
LSK cells precluded ChIP-seq analysis within this compart-
ment. The immortalized HPC-BM cell line retains the HSC
characteristics of self-renewal and multilineage potential in
vivo without leukemic transformation (33), thus providing a
surrogate HSPC transcriptional environment. Analyses of Cbp
ChIP-seq data in comparison with control IgG data identified
a total of 3,228 peaks associated with 2,395 genes, with 1,456
peaks (45.1%) located in the intergenic regions, 671 peaks
(20.8%) in the promoter regions, and 1,101 peaks (34.1%) in
the intragenic regions (Fig. 7A; see also supplemental Table S4
at http://hscl.cimr.cam.ac.uk/genomic_supplementary.html).
GSEA, using all genes bound by Cbp as the enquiry gene set,
showed that these potential Cbp target genes were significantly
enriched (P  0.001) in genes downregulated, but not those
upregulated, in Cbp-deficient cells, an observation in agree-
ment with the well-recognized function of Cbp as a transcrip-
tional coactivator (Fig. 7B; see also supplemental Table S5 at
http://hscl.cimr.cam.ac.uk/genomic_supplementary.html). En-
richment of binding at selected loci was confirmed by individ-
ual ChIP-qPCR (Fig. 7C). Among genes bound by Cbp were
members of the Kru¨ppel-like factor family (Klf2, Klf10,
and Klf13), Runx1, Gfi1b, and Gata2 (Fig. 7A; see also
supplemental Table S4 at http://hscl.cimr.cam.ac.uk/genomic
_supplementary.html). These genes have important functions
in hematopoiesis, cell cycle regulation, and HSC self-renewal,
further implicating Cbp function in the regulation of these
cellular processes by coordinating critical transcription factors.
Heptad target genes were strongly correlated with genes
downregulated following Cbp deletion. We therefore investi-
gated any common genes bound by both Cbp and the Heptad
factors. When we compared 2,395 genes bound by Cbp with
the 927 genes combinatorially bound by Heptad factors, there
was a highly significant overlap of 324 genes (P 6.428 e085)
(Fig. 7D; see also supplemental Table S6 at http://hscl.cimr
.cam.ac.uk/genomic_supplementary.html), implicating Cbp as
a component of the hematopoietic transcriptional network reg-
ulated by the Heptad factors. Finally, de novo motif analysis of
all peaks bound by Cbp demonstrated enrichment for Ets, Klf,
and Creb1 consensus sequences (Fig. 7E). This suggests that
the transcriptional activity of Ets (including the Heptad mem-
bers Fli1 and Erg), Klf family members, and Creb1, which are
all known to be involved in stem cell self-renewal, are coordi-
nated by Cbp in the regulation of normal HSC function.
DISCUSSION
Hematopoietic stem cells have unique properties of long-
term self-renewal and multilineage differentiation, which en-
sure the life-long production of all terminal hematopoietic
lineages. To maintain the HSC pool and prevent HSC exhaus-
tion, HSCs must precisely regulate often-antagonistic cellular
processes, such as quiescence, proliferation, apoptosis, self-
renewal, and differentiation, through tightly controlled tran-
scriptional programs (32, 54). Based on our combination of
cellular and molecular analyses, we suggest that the transcrip-
tional coactivator Cbp regulates adult HSC homeostasis (Fig.
8) through the orchestration of cell fate decisions by the com-
binatorial actions of specific transcription factors.
Following loss of Cbp in the adult HSC compartment, the
size of the LSK compartment gradually decreased, with a con-
comitant increase in the myeloid progenitor compartment.
This was accompanied by a fixed, over-2-fold increase in the
progenitor-to-LSK ratio in Cbp Mx mice, indicating an altered
balance between HSC self-renewal and myeloid differentiation
with a bias toward the latter. In addition, gene expression
analysis showed increased expression levels of myeloid differ-
entiation-related transcripts, including Mpo, Ela2, and Cd16,
and decreased lymphoid-related genes, including Rag1 in
Cbp/ LSK cells, thus providing molecular evidence for my-
eloid priming at the stem cell level following Cbp deletion.
These data provide the first evidence that loss of Cbp in adult
HSCs selectively increases myeloid over lymphoid lineage pro-
duction. It is possible that Cbp deficiency in more-differenti-
ated compartments also contributes to the differentiation de-
fects observed, as has been demonstrated in other studies
during lymphoid differentiation (19, 46).
Cbp has been shown to play a critical role during HSC
specification and early embryonic development (23, 29, 30, 41,
47). Our phenotypic and functional data, in contrast, demon-
strate a relatively milder defect upon loss of Cbp. Cbp-deficient
HSCs were able to repopulate lethally irradiated recipients,
albeit with reduced efficiency. These data are reminiscent of
the relative subtle defects in HSC function after homeostatic
loss of critical developmental regulators of hematopoiesis, such
as Scl and Runx1 (16, 26). We speculate that loss of Cbp is
compensated for by the cellular reserve of the adult HSC pool
prior to deletion and a degree of functional redundancy with
the paralogous coactivator p300 at the molecular level. Never-
theless, under the replicative stress of serial transplantation,
and to a lesser extent following in vivo 5-FU treatment, Cbp-
excised BM cells demonstrated an obvious inability to maintain
the stem cell pool, indicating a marked and predominantly
cell-autonomous defect in HSC self-renewal. The self-renewal
potential is determined by the size of the stem cell pool, which
is in turn influenced by the rate of loss of HSCs through
apoptosis or differentiation and by the proliferative state of this
pool. In addition to preferential differentiation of the HSC
compartment, we demonstrated an increase in apoptosis and
quiescence within the Cbp/ LSK compartment, which cu-
mulatively led to stem cell exhaustion (Fig. 8). These results
provide the first detailed mechanistic data to account for the
function of Cbp in adult HSC homeostasis and demonstrate
that Cbp plays a role in the regulation of cellular fate decisions
in adult HSCs.
Precise regulation of the cell cycle is critical for normal HSC
function. Loss of function of many critical genes has been
shown to cause a stem cell defect through an alteration of the
balance between quiescence and cell cycle entry (14, 31). Pre-
viously, however, loss of stem cell function following deletion
of a critical regulator has been almost uniformly accompanied
by loss of quiescence and an increase in cell cycle progression.
In contrast, our data demonstrated the opposite and corrobo-
rated a recent report whereby stabilization of Hif-1 through
biallelic loss of the E3 ubiquitin ligase von Hippel-Lindau
(VHL) protein also resulted in increased quiescence, a de-
crease in cell cycle entry, and a loss of HSC number and
function (40). These data demonstrated that an increase in
HSC quiescence may actually be detrimental to HSC function
rather than protective, as has been seen following deletion of
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the Mef/Elf4 transcription factor (24), and the data further
enforce the notion that exquisite control of the cell cycle is
critical during adult HSC homeostasis. The mechanisms that
regulate quiescence in stem cells are still poorly understood.
However, a complex interplay between signals transduced from
the stem cell niche through ligand-cell surface receptor mod-
ules, such as the Cxcl12-Cxcr4 (28) and Tpo-cMpl (49) axes,
appear to control cell cycle entry and progression through
intrinsic factors, such as Pten (48, 50), Gfi1/Gfi1b (15, 20),
Cdkn1a/p21 (6), and Foxo transcription factors (27, 42). We
identified altered expression levels of many genes implicated
in cell cycle control following Cbp loss in the LSK popula-
tion enriched for hematopoietic stem cells (Fig. 6; see also
Supplemental Table S1 at http://hscl.cimr.cam.ac.uk/genomic
_supplementary.html), and it is likely that the cell cycle phe-
notype observed is a composite of these net transcriptional
changes. For example, an alteration of the balance of cell cycle
entry toward quiescence may be explained, at least in part, by
an upregulation of Cxcl12 and Gfi1b, both positive regulators
of quiescence, with Cxcl12 potentially forming an autocrine
loop with Cxcr4 in HSCs. Although another positive regulator,
Cdkn1a, was actually downregulated in this same analysis,
these findings along with a loss of negative regulation of Foxo
factors through Cbp-mediated acetylation (44) would be pre-
dicted to favor an increase of quiescence in HSCs.
In this study, we have provided the first genome-wide anal-
ysis of Cbp occupancy in the hematopoietic system and dem-
onstrated that Cbp integrates into an HSC-specific transcrip-
tional network (45). This “Heptad network” has been
reconstructed from combinatorial genome-wide binding pat-
terns in a stem cell model cell line and comprises seven tran-
scription factors well known to regulate stem cell quiescence,
self-renewal, and differentiation. Comparison of the combina-
torial binding patterns of these Heptad factors revealed a
highly significant overlap with genes downregulated upon Cbp
loss in LSK cells and with our own Cbp genome-wide binding
pattern. Furthermore, genome-wide motif analysis of Cbp-
binding peaks revealed enrichment for consensus Ets binding
sites (Fli1 and Erg are Ets family members). In addition, it is
likely that Cbp coordinates additional transcriptional net-
works, as was evidenced by the motif enrichment for Klf and
Creb1 consensus sequences at Cbp-bound regions. Kru¨ppel-
like factor family members have been implicated in ES cell
self-renewal, and Klf4 is one of the four transcription factors
required to reverse the highly differentiated state of somatic
cells back to pluripotency (17, 38). Creb1/CREB1 has been
demonstrated to be a critical regulator of both normal hema-
topoiesis and leukemogenesis (5, 36). We propose that Cbp
may further regulate the function of these networks at a subset
of loci through acetylation of histone and nonhistone proteins
FIG. 7. ChIP-seq analysis identified the potential hematopoietic transcription network coordinated by Cbp. (A) Representative ChIP-seq data,
showing Cbp binding at the Klf2 and Runx1 loci. The scale of enrichment is shown to the left of the data. The relationships of a gene to the peaks
and the genomic scale are shown below and above the individual tracks, respectively. (B) GSEA plot demonstrating that genes bound by Cbp are
strongly correlated with genes downregulated in Cbp/ LSK. (C) Real-time PCR verification of several genomic loci. The MyoD promoter region
was used as a negative binding region. Results are from 2 individual PCR assays. Data are presented as means  standard errors of the means.
(D) Significant overlaps between genes bound by Cbp and the Heptad factors. The UCSC Genome Browser tracks demonstrate an example of Cbp
binding at the Runx1 intragenic region, which is also bound by the Heptad factors (black box). (E) A de novo motif discovery identified Ets, Klf,
and Creb1 motifs preferentially bound by Cbp.
FIG. 8. Cbp regulates HSC fate decisions. The schematic diagram summarizes the role of Cbp in the maintenance of the HSC pool. The HSC
pool is normally maintained through self-renewal, which reflects an ordered balance of proliferation and differentiation of HSCs with minimal cell
death (left panel). In contrast, in Cbp/ HSCs (right panel), these critical cell fate decisions are altered, leading to an increase in quiescence and
apoptosis, to preferential differentiation, and ultimately HSC exhaustion through decreased self-renewal (red arrows). Based on our integrated
genomic analyses, we propose that this occurs through the inability of Cbp/ HSCs to properly coordinate the transcriptional programs necessary
to regulate these cell fate decisions.
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(including Heptad members, such as Runx1 and Gata2) (13,
21) and/or by providing a protein scaffold for nucleation of
network members and other high-order transcriptional com-
plex members.
Taken together, our data demonstrate that Cbp orchestrates
multiple critical cell fate decisions in HSCs and suggest that
this occurs through the ability of Cbp to integrate the tran-
scriptional programs that mediate these decisions. In this re-
spect, it behaves similarly to another epigenetic regulator,
Dnmt1, to preserve HSC multipotency and self-renewal
through control of critical transcriptional programs (4, 43), a
finding that further underlines the role of epigenetic modula-
tion as an important layer of control in HSC regulation.
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